This finding is consistent with observations by Oliveira and colleagues, who reported that brain tissues from AD patients exhibit increased levels of phosphorylated eIF2α and diminished eIF2B subunit concentrations [66]. This evidence concerns the gene EIF2A and Alzheimer disease.